Dallas, TX & Brentwood, TN – [Date of Publication] – In a move poised to reshape the landscape of rehabilitative and mobility services across North America, Hanger Inc., a leading provider of orthotic and prosthetic (O&P) patient care, has announced its definitive agreement to acquire Numotion, a prominent provider of complex rehabilitation technology (CRT) and mobility products. The strategic combination will create "Hanger Numotion," an integrated platform designed to serve over 1.5 million patients annually with a comprehensive suite of solutions spanning O&P, CRT, and general mobility services.
The transaction, which will see Hanger acquire Numotion for cash, is expected to close in the fourth quarter of 2026, pending customary closing conditions. Upon completion, the newly formed entity will be controlled by Patient Square Capital, a dedicated healthcare investment firm, signaling a significant investment in the future of patient mobility and independence. Both Hanger and Numotion are slated to retain their existing brands and clinical operations, emphasizing a commitment to continuity and specialized care delivery.
This landmark merger brings together Hanger’s extensive network of 925 U.S.-based O&P clinics with Numotion’s more than 200 locations across the U.S. and Canada. The combined scale and complementary capabilities are anticipated to enhance access to care, foster greater investment in clinical talent, and accelerate product innovation across the continuum of mobility solutions. Mike Swinford, the current CEO of Numotion, will assume the leadership role as CEO of the combined Hanger Numotion, while Pete Stoy, the current CEO of Hanger, Inc., will transition from his role.
Unprecedented Consolidation in Mobility and Rehabilitation Services
The proposed acquisition of Numotion by Hanger marks a pivotal moment in the healthcare sector, particularly within the specialized fields of orthotics, prosthetics, and complex rehabilitation technology. This consolidation represents a strategic maneuver to create an unparalleled force in providing integrated mobility solutions to a vast and growing patient population.
A Landmark Merger
The announcement signifies more than just a corporate acquisition; it heralds the formation of a unified entity poised to redefine standards of care and access within a critical segment of healthcare. Hanger, with its long-standing legacy in orthotic and prosthetic patient care, brings deep clinical expertise and a widespread geographical footprint. Numotion, under the stewardship of AEA Investors prior to this deal, has carved out a niche as a leader in complex rehabilitation technology and specialized mobility products, serving individuals with significant mobility challenges. The union of these two specialized giants aims to bridge the historical gaps between these essential services, offering a more streamlined and holistic approach to patient needs.
The New Entity: Hanger Numotion
The name "Hanger Numotion" itself encapsulates the ambition of this merger: to combine the strengths and established reputations of both organizations. While the press release indicates that both companies will maintain their existing brands and clinical operations, the overarching structure under Hanger Numotion suggests a unified strategic direction. This approach aims to leverage the brand equity and specialized focus each company has cultivated, while benefiting from shared resources, operational efficiencies, and a consolidated vision at the leadership level. The continued independence of clinical operations underscores a commitment to preserving the distinct expertise and patient relationships that define both Hanger’s O&P services and Numotion’s CRT offerings.
Strategic Rationale and Market Impact
The strategic rationale behind this acquisition is multifaceted and compelling. Firstly, it addresses the increasing demand for integrated care solutions. Patients requiring orthotics or prosthetics often have underlying conditions that necessitate complex rehabilitation technology, and vice versa. By bringing these services under one umbrella, Hanger Numotion aims to simplify the patient journey, improve coordination of care, and deliver more comprehensive outcomes. Secondly, the sheer scale of the combined entity – serving over 1.5 million patients annually across more than 1,125 locations – will create a dominant market presence in North America. This scale is expected to unlock significant synergies, including enhanced purchasing power, greater investment capacity for technology and research, and an expanded ability to attract and retain top clinical talent. The market impact will be profound, potentially setting new benchmarks for service delivery and innovation in the rehabilitative and mobility sectors.
Leadership Transition and Governance
A key aspect of this transition involves the leadership structure of the combined company. Mike Swinford, who has successfully led Numotion since 2014, will step into the role of CEO for Hanger Numotion. Swinford’s extensive experience, including a significant tenure at GE Healthcare Services, positions him as a seasoned executive capable of navigating the complexities of integrating two large healthcare organizations and driving sustained growth. Pete Stoy, the current CEO of Hanger, Inc., will transition from his role, leaving behind a legacy of strengthening Hanger’s national platform and investing in its people and capabilities since 2020. The combined company will be controlled by Patient Square Capital, whose involvement as a dedicated healthcare investor underscores a long-term strategic commitment to maximizing the value and impact of Hanger Numotion within the healthcare ecosystem.
Awaiting Regulatory Approval
While the announcement is met with enthusiasm, the transaction is subject to customary closing conditions, including regulatory approvals. Given the significant scale and market share the combined entity will command, antitrust reviews will be a critical step in the process. Such reviews typically assess potential impacts on competition, patient choice, and pricing within the relevant markets. The expectation of a Q4 2026 closing suggests a thorough and potentially lengthy review period, reflecting the complexity and magnitude of the deal.
Chronology: Tracing the Path to Formation
The formation of Hanger Numotion is the culmination of distinct evolutionary paths for both companies, punctuated by strategic growth, market leadership, and the influential role of private equity investment. Understanding this history provides context for the significance of their impending union.
The Genesis of Hanger: A Legacy of O&P Care
Hanger Inc. boasts a rich history rooted in the very beginnings of modern orthotics and prosthetics. Founded in 1861 by James Edward Hanger, who lost his leg in the Civil War and designed his own prosthetic limb, the company has evolved from a pioneering individual effort into the largest provider of O&P patient care services in the United States. Over more than a century and a half, Hanger has built an unparalleled network of clinics, establishing itself as a leader in innovative limb replacement and bracing solutions. Its growth has been fueled by a steadfast commitment to clinical excellence, technological advancement, and a patient-centric philosophy. Hanger’s enduring presence and expertise in O&P have made it a trusted name for generations of patients seeking to restore mobility and function.
Numotion’s Evolution: A Leader in CRT
Numotion, while a more recent entrant compared to Hanger’s long history, has rapidly ascended to become a preeminent provider of Complex Rehabilitation Technology (CRT) and mobility products and services across the U.S. and Canada. CRT encompasses highly individualized, medically necessary mobility solutions, such as custom power wheelchairs, manual wheelchairs, and adaptive seating systems, designed to meet the unique needs of individuals with severe disabilities and complex medical conditions. Numotion’s rise has been characterized by strategic expansions, a focus on specialized clinical expertise, and a dedication to empowering individuals with greater independence. Its growth trajectory has been particularly notable since 2014 under the leadership of Mike Swinford, who diversified its offerings and scaled its operations significantly.
The Role of Private Equity: Fueling Growth and Consolidation
Private equity firms have played a crucial role in the growth trajectories of both Hanger and Numotion, and their involvement underscores a broader trend of investment in specialized healthcare services. Numotion, for instance, has been a portfolio company of AEA Investors, a leading global private investment firm. AEA’s backing likely provided the capital and strategic guidance necessary for Numotion to expand its market presence and enhance its service offerings. Similarly, the control of the combined Hanger Numotion by Patient Square Capital highlights the strategic interest of investment firms in consolidating and optimizing critical healthcare sectors. Patient Square Capital, known for its focus on healthcare innovation and value creation, sees significant potential in an integrated mobility platform. Private equity investment often provides the resources for aggressive expansion, technological upgrades, and the strategic mergers and acquisitions that drive industry consolidation.
The Merging of Visions: Initial Discussions to Definitive Agreement
While the specific details of the negotiation process remain private, the eventual agreement between Hanger and Numotion likely stemmed from a recognition of their complementary strengths and a shared vision for integrated patient care. The leadership teams, particularly Mike Swinford and Pete Stoy, appear to have engaged in extensive discussions to align their companies’ missions and operational strategies. The strategic rationale – creating a scaled North American platform with complementary capabilities – would have been the guiding principle throughout the negotiation. This process would have involved meticulous due diligence, valuation assessments, and the crafting of a definitive agreement that addresses operational integration, leadership transition, and financial structuring.
Anticipated Closing Timeline
The announced closing timeline for the transaction, expected in the fourth quarter of 2026, suggests a carefully planned and extensive integration process. Such a lengthy period is typical for large, complex mergers in highly regulated industries. It accounts for the time needed to secure all necessary regulatory approvals, particularly from antitrust authorities in both the U.S. and Canada, given the significant market presence of the combined entity. Furthermore, it allows for detailed planning of the operational integration, ensuring a smooth transition for employees, clinicians, and most importantly, patients, without disrupting essential services.
Supporting Data: Market Dynamics and the Power of Scale
The merger between Hanger and Numotion is not merely a corporate transaction; it’s a response to evolving market dynamics within healthcare, driven by demographic shifts, technological advancements, and the increasing demand for comprehensive, patient-centered solutions. The combined entity’s scale will position it uniquely to capitalize on these trends.
The Orthotics and Prosthetics (O&P) Landscape
The O&P market is a vital component of rehabilitative medicine, addressing the needs of individuals requiring artificial limbs (prosthetics) or supportive devices (orthotics) due to congenital conditions, trauma, disease, or aging.
- Market Size and Growth Drivers: The global O&P market is substantial, valued in the tens of billions of dollars, with steady growth projected. Key drivers include an aging global population, which correlates with higher incidences of conditions like diabetes (leading to amputations) and osteoarthritis (requiring bracing). Furthermore, advancements in surgical techniques, military conflicts, and an increase in sports-related injuries contribute to the demand.
- Patient Needs and Personalized Care: O&P care is inherently personalized, requiring highly skilled clinicians to assess, design, fabricate, and fit custom devices. The effectiveness of these devices directly impacts a patient’s mobility, independence, and quality of life. The Hanger network’s expertise in this area is paramount.
- Challenges: The O&P sector faces challenges such as complex reimbursement landscapes, which vary significantly by payer and region, and a persistent shortage of qualified O&P professionals. Investment in training, technology, and advocacy is crucial for sustained growth.
Complex Rehabilitation Technology (CRT) and Mobility Solutions
CRT represents a specialized segment of durable medical equipment (DME) that provides highly customized mobility and seating systems for individuals with significant functional limitations and complex medical needs.
- Market Size and Growth Drivers: The CRT market is also experiencing robust growth, driven by an increasing prevalence of conditions such as cerebral palsy, spinal cord injuries, multiple sclerosis, muscular dystrophy, and stroke. Advances in medical care mean more individuals with complex conditions are living longer, requiring sophisticated mobility aids.
- Criticality of Custom-Fitted Solutions: Unlike standard wheelchairs, CRT solutions are precisely tailored to each individual’s anthropometrics, postural support needs, and functional capabilities. This customization is critical for preventing secondary complications (e.g., pressure sores), promoting proper posture, and maximizing independence.
- Role of CRT in Independence and Quality of Life: For many individuals, CRT is not merely a convenience but a medical necessity that enables participation in daily life, education, employment, and community activities. Numotion’s expertise in this domain is vital for enhancing patient outcomes.
Synergies and Expanded Reach
The combination of Hanger and Numotion creates powerful synergies that extend beyond simply adding up their individual capacities.
- Combined Patient Base (1.5M+): Serving such a large and diverse patient population provides an unparalleled opportunity for data collection, outcome measurement, and the identification of best practices across a broad spectrum of conditions and needs.
- Geographic Footprint (925 Hanger clinics, 200+ Numotion locations): The extensive network across the U.S. and Canada significantly improves patient access to specialized care. For patients requiring both O&P and CRT services, this integration offers a "one-stop shop" approach, reducing logistical burdens and improving continuity of care.
- Operational Efficiencies and Shared Best Practices: Larger scale often translates to greater purchasing power for materials, components, and technology. It also allows for the standardization of administrative processes, IT systems, and clinical protocols, leading to increased efficiency and consistency in service delivery.
- Investment in R&D and Clinical Excellence: A larger, more financially robust entity can allocate greater resources to research and development, exploring cutting-edge technologies like advanced robotics, AI-driven adaptive devices, and innovative materials. Furthermore, it can invest more heavily in clinician training, continuing education, and fostering a culture of clinical excellence across all service lines.
Financial Implications and Investment Outlook
The involvement of Patient Square Capital as the controlling investor underscores the significant financial potential seen in this merger.
- Patient Square Capital’s Strategy: As a firm dedicated to healthcare, Patient Square Capital likely identifies this combined entity as a platform investment with substantial growth opportunities. Their strategy would focus on leveraging the combined scale to drive market leadership, enhance operational efficiency, and capitalize on unmet patient needs through innovation.
- Benefits of a Larger, More Diversified Platform: From an investment perspective, a diversified platform reduces risk by spreading across different service lines and patient demographics. The integration of O&P and CRT creates a more resilient business model, capable of adapting to market shifts and regulatory changes.
- Long-term Value Creation: The anticipated long-term value creation stems from improved patient outcomes, increased market penetration, enhanced operational margins through synergies, and the ability to attract further capital for future expansion and innovation. This strategic investment is a bet on the enduring and growing demand for high-quality, integrated mobility solutions.
Official Responses: Voices from the Helm
The statements from the leaders of Hanger and Numotion reflect a shared vision for the future, emphasizing the profound impact this merger is expected to have on patient care and the broader mobility industry. Their comments highlight strategic alignment, mutual respect, and a commitment to continuity and innovation.
Mike Swinford on Vision and Integration
Mike Swinford, who will assume the role of CEO for the combined Hanger Numotion, articulated a clear and compelling vision for the new entity. "Our two companies share a fundamental belief in the role mobility can play in improving people’s lives. By bringing together our respective experience, capabilities, and passion to serve our customers and patients, we have an opportunity to build on each company’s strengths and help more people across their mobility journeys," Swinford stated. This emphasizes a patient-centric philosophy that transcends individual company identities, focusing instead on the holistic needs of individuals requiring mobility solutions.
Swinford’s extensive background at Numotion since 2014, where he successfully scaled the business into a mobility leader through sustained growth and diversification, positions him as a natural choice for the CEO role. His prior experience as President and CEO of GE Healthcare Services further underscores his capability to lead a large, complex healthcare organization. His acknowledgment of previous partners, stating, "I’d like to personally thank Pete for his outstanding leadership, AEA for its strong partnership and commitment as Numotion’s primary investor, and LLR for its longstanding investment in and support of the company," speaks to a collaborative spirit and recognition of the foundations upon which this new entity will be built. Swinford’s commitment to working with teams across Hanger, Numotion, and Patient Square signals a focused approach to integration, driven by the shared goal of enhancing lives through greater mobility and independence.
Pete Stoy on Hanger’s Transformation and Future Leadership
Pete Stoy, the outgoing CEO of Hanger, Inc., reflected with pride on his tenure and expressed strong confidence in Mike Swinford’s ability to lead the combined organization. "I am incredibly proud of what our team has accomplished at Hanger and the transformation the business has undergone since I joined the company in 2020. Together, we have built a stronger, more integrated national platform, invested meaningfully in our people, technology, and capabilities, and positioned Hanger for sustained growth," Stoy remarked. This statement highlights the significant strategic and operational improvements Hanger has made under his leadership, laying a solid foundation for the merger.
Stoy’s endorsement of Swinford is particularly noteworthy: "I have worked with Mike closely throughout this process, and I have tremendous confidence in his ability to lead Hanger Numotion following the close of the transaction. He is an accomplished leader who shares our commitment to patients and our people, and I believe he is well-positioned to build on Hanger’s momentum and realize the tremendous potential of the combined organization ahead." This shows a seamless transition of leadership built on mutual respect and a shared understanding of the strategic imperatives for the combined company. It reinforces the idea that the merger is a natural progression, aimed at maximizing collective strengths for the benefit of patients and the industry at large.
Perspectives from Patient Square Capital
While Patient Square Capital did not issue a direct quote in the initial announcement, their role as the controlling entity speaks volumes about their investment philosophy and strategic alignment. Patient Square Capital is known for its deep expertise in the healthcare sector, focusing on companies that demonstrate significant potential for innovation, growth, and positive patient impact. Their investment in Hanger Numotion aligns perfectly with a strategy to back market leaders that can deliver integrated solutions in areas of high unmet need. The firm likely sees the combined entity as a robust platform to drive long-term value creation by expanding access to essential services, investing in cutting-edge technology, and optimizing operational efficiencies across a vast network. Their control signifies a long-term commitment to nurturing this new entity into a dominant force in the North American mobility and rehabilitation landscape, emphasizing sustainable growth and enhanced patient outcomes.
Implications: A New Era for Patient Care and Industry Evolution
The formation of Hanger Numotion heralds a new era for patient care, promising to redefine the standards of service, foster innovation, and reshape the competitive dynamics within the orthotics, prosthetics, and complex rehabilitation technology sectors.
Enhanced Patient Access and Continuum of Care
One of the most significant implications of this merger is the promise of enhanced patient access and a more seamless continuum of care. Patients often navigate a fragmented healthcare system, seeking O&P services from one provider and CRT from another. The combined Hanger Numotion platform will offer a holistic approach, enabling individuals to access a broader spectrum of mobility solutions from a single, integrated provider. This means easier referrals, better coordination between O&P and CRT specialists, and a more streamlined patient journey. For individuals with complex or progressive conditions, this integration could lead to earlier interventions, more comprehensive treatment plans, and ultimately, improved long-term outcomes and quality of life. The extensive geographic footprint ensures that specialized care is brought closer to more communities across North America.
Impact on Clinicians and Talent Development
The merger is expected to have a profound positive impact on clinicians. By creating a larger, more diversified organization, Hanger Numotion will likely offer expanded opportunities for professional growth, cross-training, and collaboration between O&P and CRT specialists. This interdisciplinary environment can foster a richer learning experience, allowing clinicians to broaden their skill sets and gain exposure to a wider range of patient needs and technological solutions. The increased scale and resources will also enable greater investment in continuing education, advanced certifications, and the adoption of cutting-edge technologies that empower clinicians to deliver even higher quality care. For prospective talent, Hanger Numotion could become a highly attractive employer, drawing top professionals seeking a supportive, innovative, and impactful career path in rehabilitative medicine, potentially mitigating existing talent shortages in these specialized fields.
Driving Innovation and Product Development
The combined entity’s substantial size and financial backing from Patient Square Capital are expected to significantly accelerate innovation and product development. A larger research and development budget can be allocated to exploring advancements in materials science, prosthetic design, robotic assistance for mobility devices, and AI-driven assessment tools. The vast patient data collected from over 1.5 million annual patient interactions can inform product design, identify unmet needs, and validate the effectiveness of new solutions. This robust innovation pipeline promises to bring more advanced, customized, and effective mobility solutions to market faster, benefiting patients with enhanced functionality, comfort, and independence. The collaboration between O&P and CRT experts under one roof can also spark cross-pollination of ideas, leading to truly novel hybrid solutions.
Competitive Landscape and Regulatory Scrutiny
The formation of Hanger Numotion will undoubtedly alter the competitive landscape in the O&P and CRT markets. The new entity will emerge as a dominant player, potentially prompting other smaller and mid-sized providers to consider strategic alliances or further consolidation to compete effectively. While this could lead to a more efficient market, it will also likely draw significant scrutiny from antitrust regulators. Authorities will examine the potential for reduced competition, impacts on pricing, and patient choice. The long closing period (Q4 2026) suggests that both companies and Patient Square Capital anticipate a thorough regulatory review process to ensure the merger serves the public interest and maintains a competitive market environment. The outcome of these reviews will be crucial in shaping the final scope and operational parameters of Hanger Numotion.
The Future of Mobility and Independence Solutions
Looking ahead, Hanger Numotion is positioned to play a transformative role in the future of mobility and independence solutions. With an aging global population and a growing number of individuals living with chronic conditions and disabilities, the demand for sophisticated rehabilitative and mobility technologies will only increase. The integrated platform will be uniquely equipped to address these societal needs by providing comprehensive, lifelong support for individuals across their mobility journeys. By investing in clinicians, embracing technological innovation, and expanding access to care, Hanger Numotion has the potential to redefine what’s possible for people seeking to live with greater independence and dignity. This merger is more than just a business deal; it is a strategic commitment to advancing human potential through mobility.
